Company / Total Assets
Integra Lifesciences Holdings Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$3.6B
FY2025
5-year range
$3.6B / $4.0B
FY2021-FY2025
Trend
-10.8%
vs FY2024
Sector context
#70 of 161
Health Care
What the data says
At $3.6B, Integra Lifesciences Holdings's total assets ranks #70 of 161 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $1.8B in FY2016 to $4.0B in FY2024.
Based on SEC 10-K filings.
$3.6B in FY2025 with a 5-year CAGR of -0.1%.
Declined from $3.8B to $3.6B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- -0.1%
- 10-Year CAGR
- -
Sector benchmark
#70 of 161 in Health CareTop 43% of 161This company $3.6B Sector average $14.8B
▼
-75.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.1%, indicating a declining trend.
- In FY2025, total assets decreased 10.8% year-over-year.
- Ranks #70 out of 161 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6B | -10.8% |
| FY2024 | $4.0B | +6.8% |
| FY2023 | $3.8B | -2.8% |
| FY2022 | $3.9B | +2.8% |
| FY2021 | $3.8B | +4.6% |
| FY2020 | $3.6B | +9.4% |
| FY2019 | $3.3B | +6.3% |
| FY2018 | $3.1B | -3.2% |
| FY2017 | $3.2B | +77.6% |
| FY2016 | $1.8B | +1.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026